Levofolinate

Role

Indications

Reactions

Secondary

Colon Cancer	17.7%
Rectal Cancer Metastatic	17.4%
Colon Cancer Recurrent	16.5%
Colon Cancer Metastatic	14.4%
Large Intestine Carcinoma	9.4%
Rectal Cancer	3.8%
Prophylaxis Of Nausea And Vomiting	3.5%
Rectal Cancer Recurrent	3.4%
Prophylaxis	2.3%
Drug Use For Unknown Indication	2.1%
Colorectal Cancer	1.6%
Product Used For Unknown Indication	1.6%
Pancreatic Carcinoma	1.5%
Vomiting	1.2%
Burkitt's Lymphoma Stage Iv	0.7%
Hypertension	0.7%
Insomnia	0.7%
Pneumonia	0.6%
Cancer Pain	0.5%
Colorectal Cancer Metastatic	0.5%

White Blood Cell Count Decreased	20.0%
Interstitial Lung Disease	17.0%
Neutrophil Count Decreased	9.0%
Hypertension	6.0%
Mechanical Ileus	5.0%
Hyperglycaemia	4.0%
Nausea	4.0%
Short-bowel Syndrome	4.0%
Skin Disorder	4.0%
Stomatitis	4.0%
Paraesthesia	3.0%
Peptic Ulcer	3.0%
Shock Haemorrhagic	3.0%
Colitis Ischaemic	2.0%
Gastrointestinal Perforation	2.0%
Ileal Ulcer	2.0%
Multi-organ Failure	2.0%
Myelodysplastic Syndrome	2.0%
Peritonitis	2.0%
Polymyositis	2.0%

Concomitant

Colon Cancer Metastatic	23.3%
Rectal Cancer Metastatic	16.4%
Colon Cancer	14.7%
Large Intestine Carcinoma	8.3%
Rectal Cancer Recurrent	8.1%
Colon Cancer Recurrent	7.4%
Colorectal Cancer	4.4%
Rectal Cancer	3.9%
Small Intestine Carcinoma Recurrent	2.2%
Prophylaxis	2.2%
Prophylaxis Of Nausea And Vomiting	2.1%
Colorectal Cancer Metastatic	1.5%
Hypertension	1.1%
Small Intestine Carcinoma Metastatic	0.9%
Pain	0.8%
Premedication	0.8%
Constipation	0.5%
Burkitt's Leukaemia	0.5%
Product Used For Unknown Indication	0.5%
Anal Cancer	0.4%

Interstitial Lung Disease	16.3%
Vomiting	9.2%
Septic Shock	7.2%
Peritonitis	6.5%
Sepsis	5.9%
Pulmonary Embolism	4.6%
Stomatitis	4.6%
Congestive Cardiomyopathy	3.9%
Disease Progression	3.9%
Jaundice	3.9%
Large Intestine Perforation	3.9%
Respiratory Failure	3.9%
Staphylococcal Infection	3.9%
Gastrointestinal Perforation	3.3%
Lung Disorder	3.3%
Neuropathy Peripheral	3.3%
Pyrexia	3.3%
Shock	3.3%
Suture Rupture	3.3%
Convulsion	2.6%